Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Minerva Stomatologica
|
April 27, 2004
In vitro buffering properties of 3 composite resins
P Passi, A Zadro, S Varotto, et al.
Journal of Materials Science. Materials in Medicine
|
September 7, 2004
PIXE micro-beam mapping of metals in human peri-implant tissues
P Passi, A Zadro, S Galassini, et al.
Journal of Materials Science. Materials in Medicine
|
September 7, 2004
Plain and drug loaded polyphosphazene membranes and microspheres in the treatment of rabbit bone defects
P Passi, A Zadro, F Marsilio, et al.
Tumori
|
March 18, 1999
Ifosfamide bolus followed by five days continuous infusion in extensively pretreated patients with advanced breast cancer: a phase II study
G Bisagni, C Boni, A L Manenti, et al.
Investigative Ophthalmology & Visual Science
|
December 9, 2008
XIAP effects on retinal detachment-induced photoreceptor apoptosis [corrected]
Laura A Zadro-Lamoureux, David N Zacks, Adam N Baker, et al.
Breast Cancer Research and Treatment
|
November 26, 1999
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial
G Cocconi, G Bisagni, G Ceci, et al.
Tumori
|
November 1, 1996
Neoadjuvant chemotherapy with continuous infusion of cisplatin and fluorouracil in stage II-IV, M0 squamous cell carcinoma of the head and neck
C Boni, G Moretti, L Savoldi, et al.
International Journal of Cancer
|
August 5, 2000
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC)
C Boni, G Bisagni, L Savoldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 1999
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
C Boni, L Savoldi, G Bisagni, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Minerva Stomatologica
|
April 27, 2004
In vitro buffering properties of 3 composite resins
P Passi, A Zadro, S Varotto, et al.
Journal of Materials Science. Materials in Medicine
|
September 7, 2004
PIXE micro-beam mapping of metals in human peri-implant tissues
P Passi, A Zadro, S Galassini, et al.
Journal of Materials Science. Materials in Medicine
|
September 7, 2004
Plain and drug loaded polyphosphazene membranes and microspheres in the treatment of rabbit bone defects
P Passi, A Zadro, F Marsilio, et al.
Tumori
|
March 18, 1999
Ifosfamide bolus followed by five days continuous infusion in extensively pretreated patients with advanced breast cancer: a phase II study
G Bisagni, C Boni, A L Manenti, et al.
Investigative Ophthalmology & Visual Science
|
December 9, 2008
XIAP effects on retinal detachment-induced photoreceptor apoptosis [corrected]
Laura A Zadro-Lamoureux, David N Zacks, Adam N Baker, et al.
Breast Cancer Research and Treatment
|
November 26, 1999
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial
G Cocconi, G Bisagni, G Ceci, et al.
Tumori
|
November 1, 1996
Neoadjuvant chemotherapy with continuous infusion of cisplatin and fluorouracil in stage II-IV, M0 squamous cell carcinoma of the head and neck
C Boni, G Moretti, L Savoldi, et al.
International Journal of Cancer
|
August 5, 2000
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC)
C Boni, G Bisagni, L Savoldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 1999
Bolus versus 5-day continuous infusion of cisplatin with mitomycin and vindesine in the treatment of advanced non-small cell lung cancer (NSCLC): a phase III prospective randomised trial of the Italian Oncology Group for Clinical Research (GOIRC)
C Boni, L Savoldi, G Bisagni, et al.
Page
of 1